Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective

per Ahmadiani, Saeed, Nikfar, Shekoufeh
Publicat a Daru (2016)

Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions

per Abdollahias, Akbar, Nikfar, Shekoufeh, Abdollahi, Mohammad
Publicat 2011

The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis

per Rezaie, Ali, Nikfar, Shekoufeh, Abdollahi, Mohammad
Publicat 2010

Are probiotics effective in management of irritable bowel syndrome?

per Hosseini, Asieh, Nikfar, Shekoufeh, Abdollahi, Mohammad
Publicat 2012

Current opinion on treatment of inflammatory bowel disease in pregnant women

per Salari, Pooneh, Nikfar, Shekoufeh, Abdollahi, Mohammad
Publicat 2012

Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines: A meta-analysis

per Rahimi, Roja, Nikfar, Shekoufeh, Abdollahi, Mohammad
Publicat 2013

Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients

per Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad
Publicat 2014

Direct and indirect cost of managing Alzheimer’s disease in the Islamic Republic of Iran

per Aajami, Zahra, Kebriaeezadeh, Abbas, Nikfar, Shekoufeh
Publicat a Iran J Neurol (2019)

Short and long term impacts of COVID-19 on the pharmaceutical sector

per Ayati, Nayyereh, Saiyarsarai, Parisa, Nikfar, Shekoufeh
Publicat a Daru (2020)

A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome

per Darvish-Damavandi, Mahnaz, Nikfar, Shekoufeh, Abdollahi, Mohammad
Publicat 2010

Prevention of bone resorption by intake of phytoestrogens in postmenopausal women: a meta-analysis

per Salari Sharif, Pooneh, Nikfar, Shekoufeh, Abdollahi, Mohammad
Publicat 2010

Is Certolizumab Pegol Safe and Effective in the Treatment of Patients with Moderate to Severe Crohn’s Disease? A Meta-analysis of Controlled Clinical Trials

per Nikfar, Shekoufeh, Ehteshami-Afshar, Solmaz, Abdollahi, Mohammad
Publicat 2013

Evaluation of prescriptions of medicines not included in Iran medicine list: A cross-sectional study

per Zargaran, Marzieh, Nikfar, Shekoufeh, Cheraghali, Abdol Majid
Publicat a J Res Pharm Pract (2016)

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran

per Nikfar, Shekoufeh, Kebriaeezadeh, Abbas, Majdzadeh, Reza, Abdollahi, Mohammad
Publicat 2005

Efficacy of tricyclic antidepressants in irritable bowel syndrome: A meta-analysis

per Rahimi, Roja, Nikfar, Shekoufeh, Rezaie, Ali, Abdollahi, Mohammad
Publicat 2009

A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis

per Nikfar, Shekoufeh, Rahimi, Roja, Rezaie, Ali, Abdollahi, Mohammad
Publicat 2010

Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated met...

per Nikfar, Shekoufeh, Rahimi, Roja, Hendoiee, Narjes, Abdollahi, Mohammad
Publicat 2012

Pharmaceutical supply chain risks: a systematic review

per Jaberidoost, Mona, Nikfar, Shekoufeh, Abdollahiasl, Akbar, Dinarvand, Rassoul
Publicat 2013

Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis

per Didari, Tina, Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad
Publicat a World J Gastroenterol (2015)

Tumor Necrosis Factor-alpha Antibodies in Fistulizing Crohn's Disease: An Updated Systematic Review and Meta-analysis

per Zaboli, Pardis, Abdollahi, Mohammad, Mozaffari, Shilan, Nikfar, Shekoufeh
Publicat a J Res Pharm Pract (2017)